alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Rene J. BRYANT, Appellant, v. Richard L. DUGGER, Secretary, Department of Corrections, Appellee.

No. BT-246.

District Court of Appeal of Florida, First District.

June 1, 1988.

*1024Rene J. Bryant, in pro. per.

Robert A. Butterworth, Atty. Gen., and Bradford L. Thomas, Asst. Atty. Gen., Tallahassee, for appellee.

PER CURIAM.

Appellant filed a petition for habeas corpus or, in the alternative, a writ as the court may deem appropriate, in the . Baker County Circuit Court. Appellant alleged that his sentence, imposed by the Clay County Circuit Court, is illegal. The trial court’s denial of the petition is affirmed without prejudice for appellant to file a motion in the court which sentenced him for such relief, if any, as may be afforded by Rule 3.850, Florida Rules of Criminal Procedure.

ERVIN, BOOTH and WENTWORTH, JJ., concur.
[Federal Register Volume 77, Number 46 (Thursday, March 8, 2012)]
[Notices]
[Page 14004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-5601]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration

RIN 0648-XB064


New England Fishery Management Council; Public Meeting

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Notice; public meeting.

-----------------------------------------------------------------------

SUMMARY: The New England Fishery Management Council's (Council) VMS/
Enforcement Committee and Advisory Panel will meet to consider actions 
affecting New England fisheries in the exclusive economic zone (EEZ).

DATES: The meeting will be held on Thursday, March 22, 2012 at 9 a.m.

ADDRESSES: The meeting will be held at the Holiday Inn by the Bay, 88 
Spring Street, Portland, ME 04101; telephone: (207) 775-2311; fax: 
(207) 772-4017.
    Council address: New England Fishery Management Council, 50 Water 
Street, Mill 2, Newburyport, MA 01950.

FOR FURTHER INFORMATION CONTACT: Paul J. Howard, Executive Director, 
New England Fishery Management Council; telephone: (978) 465-0492.

SUPPLEMENTARY INFORMATION:

Agenda

    The Committee and Advisory Panel will provide an open comment 
period for the fishing industry, concerning compliance and 
effectiveness of regulations for New England Fishery Management Plans 
(FMPs). They will analyze enforcement of Amendment 5 to the Atlantic 
Herring FMP. They will comment on the NOAA Enforcement priorities. They 
will also discuss an issue raised by Mid-Atlantic Fishery Management 
Council about the need for NOAA General Counsel staff in the Northeast. 
Also in the agenda will be a review of Habitat Committee information on 
coral zones. The committee will discuss Council questions about the 
verification of sector landings reports and penalties. Other business 
may be discussed.
    Although non-emergency issues not contained in this agenda may come 
before this group for discussion, those issues may not be the subject 
of formal action during this meeting. Action will be restricted to 
those issues specifically identified in this notice and any issues 
arising after publication of this notice that require emergency action 
under section 305(c) of the Magnuson-Stevens Fishery Conservation and 
Management Act, provided the public has been notified of the Council's 
intent to take final action to address the emergency.

Special Accommodations

    This meeting is physically accessible to people with disabilities. 
Requests for sign language interpretation or other auxiliary aids 
should be directed to Paul J. Howard (see ADDRESSES) at least 5 days 
prior to the meeting date.

    Authority:  16 U.S.C. 1801 et seq.

    Dated: March 2, 2012.
Tracey L. Thompson,
Acting Director, Office of Sustainable Fisheries, National Marine 
Fisheries Service.
[FR Doc. 2012-5601 Filed 3-7-12; 8:45 am]
BILLING CODE 3510-22-P
[Federal Register Volume 77, Number 51 (Thursday, March 15, 2012)]
[Notices]
[Page 15360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6445]


=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting Notice

    The following notice of a scheduled meeting is published pursuant 
to the provisions of the Government in the Sunshine Act, Public Law 94-
409, 5 U.S.C. 552b.

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIMES AND DATES: The Commission has scheduled a meeting for the 
following date: March 20, 2012 at 9:30 a.m.

PLACE: Three Lafayette Center, 1155 21st St. NW., Washington, DC, Lobby 
Level Hearing Room (Room 1300).

STATUS: Open.

MATTERS TO BE CONSIDERED: The Commission has scheduled this meeting to 
consider various rulemaking matters, including the issuance of proposed 
rules and the approval of final rules. The Commission may also consider 
and vote on dates and times for future meetings. The agenda for this 
meeting will be made available to the public and posted on the 
Commission's Web site at http://www.cftc.gov at least seven (7) days 
prior to the meeting. In the event that the time or date of the meeting 
changes, an announcement of the change, along with the new time and 
place of the meeting will be posted on the Commission's Web site.

CONTACT PERSON FOR MORE INFORMATION: David A. Stawick, Secretary of the 
Commission, 202-418-5071.

David A. Stawick,
Secretary of the Commission.
[FR Doc. 2012-6445 Filed 3-13-12; 4:15 pm]
BILLING CODE 6351-01-P
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Dynamic Health Products, Inc. (the Company) on Form 10-KSB for the year ended March 31, 2005, as filed
with the Securities and Exchange Commission on the date hereof (the Report), I, Cani I. Shuman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley
Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       
|-----------------------
|/s/ Cani I. Shuman     
|Cani I. Shuman         
|Chief Financial Officer
|July 14, 2005
II 

111TH CONGRESS 

1ST SESSION S. 2392 

To extend the temporary suspension of duty on Acetic acid, [4-(2,6-dihydro2,6-dioxo-7-phenylbenzo[1,2-b:4,5-b’]difuran -3-yl)phenoxy]-, 2- 

ethoxyethyl ester. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mrs. HAGAN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on Acetic acid, 

[4-(2,6-dihydro-2,6-dioxo-7-phenylbenzo[1,2-b:4,5- 

b’]difuran -3-yl)phenoxy]-, 2-ethoxyethyl ester. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ACETIC ACID, [4-(2,6-DIHYDRO-2,6-DIOXO-7- 

4 PHENYLBENZO[1,2-B:4,5-B’]DIFURAN -3- 

5 YL)PHENOXY]-, 2-ETHOXYETHYL ESTER. 

6 (a) IN GENERAL.—Heading 9902.24.96 of the Har7 monized Tariff Schedule of the United States (relating to 

8 Acetic acid, [4-(2,6-dihydro-2,6-dioxo-7-phenylbenzo[1,2- 

9 b:4,5-b’]difuran -3-yl)phenoxy]-, 2-ethoxyethyl ester) is 


jlentini on DSKJ8SOYB1PROD with BILLS
2 

•S 2392 IS

1 amended by striking ‘‘12/31/2009’’ and inserting ‘‘12/31/ 

2 2011’’. 

3 (b) EFFECTIVE DATE.—The amendment made by 

4 subsection (a) applies to goods entered, or withdrawn from 

5 warehouse for consumption, on or after the 15th day after 

6 the date of the enactment of this Act. 

Æ 


jlentini on DSKJ8SOYB1PROD with BILLS
#### Ernest N. COLEMAN, Appellant, v. STATE of Florida, Appellee.

Nos. 88-1950, 88-1951.

District Court of Appeal of Florida, Fifth District.

June 1, 1989.

James B. Gibson, Public Defender, and Nancye R. Crouch, Asst. Public Defender, Daytona Beach, for appellant.

Robert A. Butterworth, Atty. Gen., Tallahassee, and Paula C. Coffman, Asst. Atty. Gen., Daytona Beach, for appellee.

PER CURIAM.

DISMISSED on the authority of *Robinson v. State,*373 So.2d 898 (Fla.1979).

SHARP, C.J., and COWART and DANIEL, JJ., concur.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS  EXHIBIT  CONTAINS  SUMMARY  FINANCIAL   INFORMATION   EXTRACTED  FROM  THE
REGISTRANT'S CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED DECEMBER 31,
1998 AS RESTATED TO REFLECT THE  RECLASSIFICATION OF THE REGISTRANT'S DEBT. THIS
EXHIBIT IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL  STATEMENTS.
THIS  EXHIBIT  SHALL  NOT BE DEEMED  FILED FOR  PURPOSES  OF  SECTION  11 OF THE
SECURITIES ACT OF 1933 AND SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, OR
OTHERWISE  SUBJECT TO THE  LIABILITY OF SUCH  SECTION,  NOR SHALL IT BE DEEMED A
PART OF ANY OTHER FILING WHICH  INCORPORATES  THIS REPORT BY  REFERENCE,  UNLESS
SUCH OTHER FILING EXPRESSLY INCORPORATES THIS EXHIBIT BY REFERENCE.
</LEGEND>
<RESTATED>
<CIK> 949491
<NAME> VODAVI TECHNOLOGY, INC.
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<EXCHANGE-RATE>                                      1
<CASH>                                             796
<SECURITIES>                                         0
<RECEIVABLES>                                    9,562
<ALLOWANCES>                                       674
<INVENTORY>                                      6,385
<CURRENT-ASSETS>                                16,766
<PP&E>                                           4,291
<DEPRECIATION>                                   1,628
<TOTAL-ASSETS>                                  22,842
<CURRENT-LIABILITIES>                           12,044
<BONDS>                                            324
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             4
<OTHER-SE>                                      10,595
<TOTAL-LIABILITY-AND-EQUITY>                    22,842
<SALES>                                         47,983
<TOTAL-REVENUES>                                47,983
<CGS>                                           32,124
<TOTAL-COSTS>                                   32,124
<OTHER-EXPENSES>                                14,415
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 791
<INCOME-PRETAX>                                    653
<INCOME-TAX>                                     (330)
<INCOME-CONTINUING>                                983
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       983
<EPS-BASIC>                                        .23
<EPS-DILUTED>                                      .23


</TABLE>
<PAGE>




                                                                    Exhibit 23.2



              CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

We have issued our report dated January 30, 2001, except for the second
paragraph of Note 17, as to which the date is February 26, 2001, on the
consolidated balance sheets of MFN Financial Corporation and subsidiaries
(Reorganized Company) as of December 31, 2000 and 1999 and the related
consolidated statements of income, changes in stockholders'equity and cash flows
of MFN Financial Corporation for the year ended December 31, 2000, and for the
nine-month period from April 1, 1999 through December 31, 1999 and of Mercury
Finance Company (Predecessor Company) for the three-month period ended March 31,
1999, included in its Annual Report on Form 10-K for the year ended December 31,
2000 filed with the Securities and Exchange Commission.  We hereby consent to
the incorporation by reference of our report in the Registration Statement (Form
S-8 - File No. 333-35770) of MFN Financial Corporation, pertaining to (i) the
MFN Financial Corporation Amended and Restated 1989 Stock Option and Incentive
Compensation Plan and (ii) the Executive Option Plan.




                                       /S/ GRANT THORNTON LLP

Chicago, Illinois
March 5, 2001
Exhibit
32.1





Certification of Principal
Executive Officer


Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to


Section
906 of the Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report
of SRKP 5, Inc. (the "Company") on Form 10-Q for the period ending September 30,
2009 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Richard A. Rappaport, certify, pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to
my knowledge:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/ Richard A. RappaportRichard
      A. RappaportPrincipal
      Executive OfficerOctober
      23, 2009
May 22, 2018



### JUDGMENT 

## The Fourteenth Court of Appeals

JESUS AVALOS AND MARIA AVA LOS , Appellant s
NO. 14

- 18

- 00047

- CV V.

SEAWAY CRUDE PIPELIN E COMPANY LLC , Appellee

________________________________ Today the Court heard appellant s ’ motion to dismiss the appeal from the judgment signed by the court below on October 24, 2017. Having considered the motion and found it meritorious, we order the appeal DISMISSED

. We further order that a ppellants shall pay the costs appellants incurred and appellee shall pay the costs it incurred by reason of this appeal. We further order that mandate be issued immediately.

We further order thi s decision certified below for observance.
#### Lirnio MACHIN, Appellant, v. STATE of Florida, Appellee.

No. 4-86-1832.

District Court of Appeal of Florida, Fourth District.

Feb. 11, 1987.

Lirnio Machín, pro se.

No appearance required for appellee.

PER CURIAM.

The trial court’s order of June 20, 1986, is affirmed without prejudice to file in the circuit court a properly verified motion for post-conviction relief pursuant to Florida Rule of Criminal Procedure 3.850.

DOWNEY, ANSTEAD and LETTS, JJ., concur.
EXHIBIT 32.1
 
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
 PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 I, Dr. Sean D. Williams, Chief Executive Officer of Webtradex International, Corp. (the "Company"), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
  (1) The Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 /s/ Dr. Sean D. Williams
 Dr. Sean D. Williams
 Chief Executive Officer
 
 Date: February 15, 2011
  ___________
 This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
 
 A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              SEP-27-1998
<PERIOD-START>                                 SEP-29-1997
<PERIOD-END>                                   SEP-27-1998
<CASH>                                           5,815
<SECURITIES>                                     3,651
<RECEIVABLES>                                    6,283
<ALLOWANCES>                                     1,076
<INVENTORY>                                      9,059
<CURRENT-ASSETS>                                27,699
<PP&E>                                          29,455
<DEPRECIATION>                                  70,830
<TOTAL-ASSETS>                                  47,544
<CURRENT-LIABILITIES>                           10,913
<BONDS>                                          4,354
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            92
<OTHER-SE>                                      32,185
<TOTAL-LIABILITY-AND-EQUITY>                    47,544
<SALES>                                         45,682
<TOTAL-REVENUES>                                46,210
<CGS>                                           24,831
<TOTAL-COSTS>                                   24,831
<OTHER-EXPENSES>                                17,118
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 413
<INCOME-PRETAX>                                  4,522
<INCOME-TAX>                                    (2,683)
<INCOME-CONTINUING>                              7,205
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                        7,205
<NET-INCOME>                                     7,205
<EPS-PRIMARY>                                     0.79
<EPS-DILUTED>                                     0.75
        


</TABLE>
II 

111TH CONGRESS 

1ST SESSION S. 2272 

To suspend temporarily the duty on s-Methoprene. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mrs. FEINSTEIN introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on s-Methoprene. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. S-METHOPRENE. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 Isopropyl (2E,4E)-(7S)-11- 

methoxy-3,7,11- 

trimethyldodeca-2,4-dienoate 

(CAS No. 65733–16–6) (provided for in subheading 

2918.99.5000) ....................... Free No change No change On or before 

12/31/2011 ’’. 


wwoods2 on DSK1DXX6B1PROD with BILLS
2 

•S 2272 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


wwoods2 on DSK1DXX6B1PROD with BILLS
P. 1 

# OAR Box 1172 Prepped byOllie Stewart



### Document

Number: 

# 3 ) ll-A-2 1 Docket Number: 

# A-88-02

Printed 4/30/20087:58:29AM

Sheet 3 of 7P. 2 

### *U - A-Z i 

## A-88-0 2

Informatio n o n healt ho r ris k assessmen t wa s remove d fromth e docket . Thi s informatio n wa s compile d befor e th e Clea n Ai r Ac t Amendment s (1990 ) bu t wa s no t use d i n th e developmen t o f th e chromiu

mNESHAP .



## JA N ' 8 m ii; ! :
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated November 18, 2011, and published in the 
                    **Federal Register**
                     on November 28, 2011, 76 FR 72974, Johnson Matthey Pharmaceutical Materials Inc., Pharmaceutical Service, 25 Patton Road, Devens, Massachusetts 01434, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug
ScheduleAmphetamine (1100)
IIMethylphenidate (1724)
IINabilone (7379)
IIHydrocodone (9193)
IIAlfentanil (9737)
IIRemifentanil (9739)
IISufentanil (9740)
II
 The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company's primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company's customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of Johnson Matthey Pharmaceutical Materials Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Pharmaceutical Materials Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: March 8, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2012-6703 Filed 3-19-12; 8:45 am] BILLING CODE 4410-09-P